CSL (CMXHF) Other Long Term Assets : $968 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is CSL Other Long Term Assets?

CSL's other long-term assets for the quarter that ended in Dec. 2023 was $968 Mil.

CSL's quarterly other long-term assets increased from Dec. 2022 ($614 Mil) to Jun. 2023 ($1,004 Mil) but then stayed the same from Jun. 2023 ($1,004 Mil) to Dec. 2023 ($968 Mil).

CSL's annual other long-term assets declined from Jun. 2021 ($540 Mil) to Jun. 2022 ($536 Mil) but then increased from Jun. 2022 ($536 Mil) to Jun. 2023 ($1,004 Mil).

CSL Other Long Term Assets Historical Data

The historical data trend for CSL's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL Other Long Term Assets Chart

CSL Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Long Term Assets

Get a 7-Day Free Trial

401.80

558.60

540.00

535.70

1,004.00

CSL Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															539.10	535.70	613.90	1,004.00	968.00

CSL Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

CSL (CMXHF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (OTCPK:CMXHF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

CSLLY:USA CSJ:Germany CSL:Australia

Address

655 Elizabeth Street, Melbourne, VIC, AUS, 3000

Website

https://www.csl.com

CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.